307 related articles for article (PubMed ID: 5080965)
1. [Primary resistance in adult pulmonary tuberculosis in France. 3d report of the study center on Primary Resistance: 1966-1970].
Canetti G; Le Lirzin M; Gay P; Thibier R; Kreis B; Grosset J
Rev Tuberc Pneumol (Paris); 1972; 36(3):337-56. PubMed ID: 5080965
[No Abstract] [Full Text] [Related]
2. [Use of 4 antibacterial preparations in the treatment of destructive tuberculosis of the lungs].
Volkon VM; Shrentsel' OA
Probl Tuberk; 1973; 51(6):28-31. PubMed ID: 4202910
[No Abstract] [Full Text] [Related]
3. [Primary and secondary resistance in 257 cases of pulmonary tuberculosis from 1964 to 1966 at the Pneumology Service in Poitiers].
Rautlin de la Roy Y DE; Beauchant G; Brisou J; Dussouil P; Charpentier
Rev Tuberc Pneumol (Paris); 1967 Nov; 31(7):1054-9. PubMed ID: 4317484
[No Abstract] [Full Text] [Related]
4. [Preliminary findings and considerations on primary resistance to SM, INI, and PAS in the Provincial Antitubercular Association of Naples].
Romano S; Grella G
Rass Int Clin Ter; 1966 Dec; 46(23):1311-6. PubMed ID: 5997869
[No Abstract] [Full Text] [Related]
5. [Comparative results of treatment of pulmonary tuberculosis with the compounds of benzoyl-PAS-Ca-isoniazide and streptomycin-isoniazid].
Favez G; Gonin JD; Gubéran E; de Kalbermatten JP; Vulliémoz P; Willa C
Schweiz Med Wochenschr; 1969 Feb; 99(5):150-6. PubMed ID: 4974643
[No Abstract] [Full Text] [Related]
6. [Proceedings: Results of a controlled trial of intermittent ambulatory therapy of infectious pulmonary tuberculosis with comparison of various maintenance regimens].
Ganguin HG; Cramer G; Götz J; Holzhauer H; Niegsch G; Sieler H; Velten G; Völker L
Z Erkr Atmungsorgane Folia Bronchol; 1973; 138(1):107-15. PubMed ID: 4203235
[No Abstract] [Full Text] [Related]
7. [Proceedings: Current status and perspectives of tuberculosis chemotherapy in Algeria].
Larbaoui D; Chaulet P
Z Erkr Atmungsorgane Folia Bronchol; 1973; 138(1):139-46. PubMed ID: 4491711
[No Abstract] [Full Text] [Related]
8. [Primary resistance to the major antitubercular drugs in pulmonary tuberculosis patients during 1961-1966].
Jaroszewicz W; Buraczewska M; Pichulowa K; Pszonicka A; Zych D
Gruzlica; 1968; 37(1):17-21. PubMed ID: 5720034
[No Abstract] [Full Text] [Related]
9. [Effectiveness and problems of the treatment of tuberculosis under the environmental conditions of an underdeveloped country].
Henneghien C; Ballez C; Horvath K; el-Fassi M
Acta Tuberc Pneumol Belg; 1969; 60(6):821-32. PubMed ID: 5397018
[No Abstract] [Full Text] [Related]
10. [Treatment of early detected destructive pulmonary tuberculosis].
Anfilof'eva OIu; fedotova ZN
Probl Tuberk; 1974; (12):38-41. PubMed ID: 4445134
[No Abstract] [Full Text] [Related]
11. [Test-therapy to determine the activity of minor forms of pulmonary tuberculosis].
Rastvortseva TN
Probl Tuberk; 1971; 49(6):31-4. PubMed ID: 5117826
[No Abstract] [Full Text] [Related]
12. [Pulmonary tuberculosis in aged patients: therapeutic methods and results (121 cases)].
Petitjean R; Burghard G; Chauvet J; Weitzenblum S
Rev Tuberc Pneumol (Paris); 1970 Jun; 34(4):580-6. PubMed ID: 5510325
[No Abstract] [Full Text] [Related]
13. [Intermittent treatment and simplified continuous treatment of newly-detected pulmonary tuberculosis with first-line drugs and limited PAS administration. I. Methods and results].
Stopczyk J; Niemirowska H; Pecyna-Sielewicz J; Janowiec M; Banaszkiewicz H; Czerwiński Z; Królikowska H; Krahowska M; Malecki S; Pezińska Z; Pilch Z; Przemyska B; Szustrowa I; Wardowa A
Gruzlica; 1973 Jul; 41(7):755-64. PubMed ID: 4730976
[No Abstract] [Full Text] [Related]
14. [Reasons for failures in chemotherapy of tuberculosis].
Dissmann E
Beitr Klin Erforsch Tuberk Lungenkr; 1968; 138(1):17-24. PubMed ID: 5728639
[No Abstract] [Full Text] [Related]
15. Results of one-year chemotherapy in previously untreated patients with cavernous pulmonary tuberculosis.
Zajaczkowska J; Janczy S; Buraczewska M; Korlakowski J; Zych D; Krychniak W
Pol Med J; 1966; 5(3):526-32. PubMed ID: 5920266
[No Abstract] [Full Text] [Related]
16. [Effectiveness and possibilities of application to ambulatory patients in our region of a pulmonary tuberculosis therapy by the intermittent administration (I.V.) of the triple association isoniazid-streptomycin-PAS (preliminary results after a year)].
Burghard G; Petitjean R; Schranz J; Scherrer B
Rev Tuberc Pneumol (Paris); 1970; 34(3):439-53. PubMed ID: 5515514
[No Abstract] [Full Text] [Related]
17. [Changing picture of tuberculosis during a decade].
Tveit J
Tidsskr Nor Laegeforen; 1971 Apr; 91(12):866-8. PubMed ID: 5554775
[No Abstract] [Full Text] [Related]
18. [Proceedings: Significance and limits of controlled clinical research (in pulmonary tuberculosis)].
Bignall JR
Z Erkr Atmungsorgane Folia Bronchol; 1973; 138(1):103-6. PubMed ID: 4588016
[No Abstract] [Full Text] [Related]
19. Drug sensitivity in pulmonary tuberculosis. Incidence of primary and acquired drug-resistance in 1960-1963.
Selroos O; Brander L
Acta Tuberc Pneumol Scand; 1965; 46(3):197-206. PubMed ID: 5880140
[No Abstract] [Full Text] [Related]
20. [Progress in the treatment of tuberculosis. Isoniazid plus rifomycin plus myambutol equals standard therapy].
Freerksen E
Dtsch Med Wochenschr; 1970 Jan; 95(3):139-41. PubMed ID: 5411222
[No Abstract] [Full Text] [Related]
[Next] [New Search]